Targeting KRAS in pancreatic cancer: Emerging therapeutic strategies
Author:
Publisher
Elsevier
Reference176 articles.
1. Epithelial-to-mesenchymal transition is a cause of both intrinsic and acquired resistance to KRAS G12C inhibitor in KRAS G12C-mutant non-small cell lung cancer;Adachi;Clinical Cancer Research,2020
2. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma;Aguirre;Genes & Development,2003
3. Mechanisms of resistance to KRAS(G12C)-targeted therapy;Akhave;Cancer Discovery,2021
4. Pancreatic cancer genetics;Amundadottir;International Journal of Biological Sciences,2016
5. Acquired resistance to KRAS(G12C) inhibition in cancer;Awad;The New England Journal of Medicine,2021
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Decoding the Intricate Landscape of Pancreatic Cancer: Insights into Tumor Biology, Microenvironment, and Therapeutic Interventions;Cancers;2024-07-02
2. Single‐cell RNA sequencing reveals the mechanism of PI3K/AKT/mTOR signaling pathway activation in lung adenocarcinoma by KRAS mutation;The Journal of Gene Medicine;2024-01
3. Vasohibin-2-Targeting Therapies for the Treatment of Pancreatic Ductal Adenocarcinoma;The Tohoku Journal of Experimental Medicine;2024
4. Impact of KRAS mutation on the tumor microenvironment in colorectal cancer;International Journal of Biological Sciences;2024
5. Revolutionizing Cancer Treatment: Unveiling New Frontiers by Targeting the (Un)Usual Suspects;Cancers;2023-12-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3